Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-25 @ 9:28 PM
Study NCT ID:
NCT05001451
Status:
TERMINATED
Last Update Posted:
2022-07-20
First Post:
2021-07-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of GDX012 in Patients With MRD Positive AML
Sponsor:
GammaDelta Therapeutics Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-03
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-05
First Submit QC Date:
None
Study First Post Date:
2021-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-18
Last Update Post Date:
2022-07-20
Last Update Post Date Type:
ACTUAL